Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-27.22%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-27.22%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
Context Therapeutics Inc fundamental performance
Across Context Therapeutics Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 10M to -$ 36M. Revenue increased in 0% of the years measured; net income in 0%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.47 | — |
1 Year2025-08-12 | $ 0.68 | -30.90% |
All Time2021-10-20 | $ 5.10 | -90.79% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2021-10-20 |
|---|---|---|---|
| Price | $ 0.47 | $ 0.68 | $ 5.10 |
| Return | — | -30.90% | -90.79% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 45M | $ 42M |
| 2025 | $ 0.00 | -$ 36M | $ 65M |
| 2024 | $ 0.00 | -$ 26M | $ 94M |
| 2023 | $ 0.00 | -$ 23M | $ 14M |
| 2022 | $ 0.00 | -$ 14M | $ 35M |
| IPO2021 | $ 0.00 | -$ 10M | $ 49M |
Explore beyond CNTX
You're looking at Context Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
